Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
These comparisons highlight the dynamic nature of obesity treatment research and the potential for continued innovation in this field
Brands that prioritize formulation science, product stability, and regulatory preparation are far more likely to create products that stand the test of time
They are limited but demonstrate safety in the tested dose range
IGF-1 LR3 in humans There are no published Phase 2 or Phase 3 human RCTs evaluating IGF-1 LR3 for body composition, fat loss, or muscle accretion in healthy or metabolically compromised adults
US$ 22.29
US$ 21.24
US$ 26.75
